Stock listing
NASDAQ:EVGN Evogene Ltd. Stock
Home listing (NASDAQ) of Evogene Ltd.
Follow Evogene Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:EVGN
$0.375 USD -0.006 (-1.5%)
Close on Oct 30, 2026
- Day range
- $0.365 – $0.380 USDOct 30, 2026
- Volume
- 14,734 sharesOct 30, 2026
- Market cap
- $5.09M USDAt the close on Oct 30, 2026 · price × 13.59M shares outstanding
- 52-week range
- $0.347 – $1.290 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $609,360 USDMedian day 109,500 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EVGN · Home | $0.375 USD | -0.006 (-1.5%) | 14,734 | $0.378 | $0.380 | $0.365 | $0.380 | Close on Oct 30, 2026 |
| TASE:EVGN | 115.90 ILA (agorot) | +0.90 (+0.8%) | 57,453 | 115.90 | 115.90 | 110.00 | 115.00 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:EVGN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.375 | -0.006 | -1.5% | $0.378 | $0.380 | $0.365 | 14,734 | |
| $0.380 | +0.006 | +1.6% | $0.360 | $0.381 | $0.360 | 13,638 | |
| $0.374 | +0.011 | +2.9% | $0.360 | $0.387 | $0.355 | 40,402 | |
| $0.364 | -0.006 | -1.7% | $0.350 | $0.364 | $0.347 | 9,713 | |
| $0.370 | +0.010 | +2.8% | $0.370 | $0.370 | $0.360 | 39,287 | |
| $0.360 | -0.020 | -5.3% | $0.370 | $0.370 | $0.360 | 9,100 | |
| $0.380 | +0.010 | +2.7% | $0.360 | $0.390 | $0.360 | 10,100 | |
| $0.370 | 0.000 | 0.0% | $0.370 | $0.380 | $0.370 | 38,000 | |
| $0.370 | 0.000 | 0.0% | $0.390 | $0.390 | $0.370 | 11,100 | |
| $0.370 | -0.020 | -5.1% | $0.380 | $0.390 | $0.350 | 117,600 | |
| $0.390 | -0.010 | -2.5% | $0.410 | $0.410 | $0.380 | 38,100 | |
| $0.400 | +0.020 | +5.3% | $0.380 | $0.400 | $0.380 | 27,100 | |
| $0.380 | -0.010 | -2.6% | $0.380 | $0.390 | $0.370 | 52,600 | |
| $0.390 | 0.000 | 0.0% | $0.390 | $0.400 | $0.370 | 87,600 | |
| $0.390 | +0.010 | +2.6% | $0.390 | $0.400 | $0.380 | 106,200 | |
| $0.380 | -0.020 | -5.0% | $0.390 | $0.390 | $0.370 | 105,900 | |
| $0.400 | -0.010 | -2.4% | $0.390 | $0.410 | $0.380 | 88,300 | |
| $0.410 | -0.010 | -2.4% | $0.430 | $0.430 | $0.390 | 82,300 | |
| $0.420 | +0.020 | +5.0% | $0.390 | $0.440 | $0.390 | 625,200 | |
| $0.400 | -0.030 | -7.0% | $0.410 | $0.410 | $0.370 | 592,900 | |
| $0.430 | -0.010 | -2.3% | $0.410 | $0.450 | $0.410 | 142,500 | |
| $0.440 | +0.040 | +10.0% | $0.380 | $0.470 | $0.380 | 821,600 | |
| $0.400 | -0.010 | -2.4% | $0.390 | $0.420 | $0.350 | 9,991,200 | |
| $0.410 | +0.030 | +7.9% | $0.370 | $0.470 | $0.360 | 60,317,200 | |
| $0.380 | -0.040 | -9.5% | $0.410 | $0.450 | $0.350 | 170,800 | |
| $0.420 | 0.000 | 0.0% | $0.420 | $0.480 | $0.420 | 76,500 | |
| $0.420 | -0.030 | -6.7% | $0.450 | $0.490 | $0.420 | 284,000 | |
| $0.450 | -0.040 | -8.2% | $0.490 | $0.490 | $0.440 | 114,900 | |
| $0.490 | +0.030 | +6.5% | $0.480 | $0.500 | $0.460 | 30,200 | |
| $0.460 | -0.040 | -8.0% | $0.520 | $0.520 | $0.460 | 131,000 | |
| $0.500 | 0.000 | 0.0% | $0.500 | $0.500 | $0.470 | 18,000 | |
| $0.500 | 0.000 | 0.0% | $0.500 | $0.500 | $0.490 | 30,500 | |
| $0.500 | -0.030 | -5.7% | $0.510 | $0.510 | $0.470 | 65,200 | |
| $0.530 | +0.040 | +8.2% | $0.480 | $0.530 | $0.480 | 154,300 | |
| $0.490 | +0.010 | +2.1% | $0.480 | $0.510 | $0.470 | 112,800 | |
| $0.480 | 0.000 | 0.0% | $0.470 | $0.500 | $0.450 | 2,459,500 | |
| $0.480 | -0.020 | -4.0% | $0.500 | $0.510 | $0.480 | 41,700 | |
| $0.500 | -0.010 | -2.0% | $0.520 | $0.530 | $0.500 | 25,700 | |
| $0.510 | -0.030 | -5.6% | $0.550 | $0.550 | $0.500 | 156,700 | |
| $0.540 | -0.010 | -1.8% | $0.540 | $0.550 | $0.520 | 62,800 | |
| $0.550 | +0.010 | +1.9% | $0.550 | $0.550 | $0.540 | 28,600 | |
| $0.540 | +0.020 | +3.8% | $0.530 | $0.550 | $0.530 | 36,400 | |
| $0.520 | -0.020 | -3.7% | $0.530 | $0.540 | $0.520 | 31,300 | |
| $0.540 | -0.010 | -1.8% | $0.550 | $0.550 | $0.510 | 161,900 | |
| $0.550 | +0.010 | +1.9% | $0.560 | $0.560 | $0.540 | 15,200 | |
| $0.540 | 0.000 | 0.0% | $0.550 | $0.560 | $0.530 | 59,500 | |
| $0.540 | -0.010 | -1.8% | $0.540 | $0.550 | $0.520 | 74,600 | |
| $0.550 | -0.010 | -1.8% | $0.560 | $0.560 | $0.530 | 113,300 | |
| $0.560 | 0.000 | 0.0% | $0.570 | $0.580 | $0.550 | 191,000 | |
| $0.560 | 0.000 | 0.0% | $0.540 | $0.580 | $0.540 | 1,033,800 | |
| $0.560 | -0.040 | -6.7% | $0.600 | $0.600 | $0.550 | 228,300 | |
| $0.600 | +0.020 | +3.4% | $0.590 | $0.610 | $0.570 | 151,800 | |
| $0.580 | +0.020 | +3.6% | $0.560 | $0.590 | $0.540 | 150,900 | |
| $0.560 | -0.040 | -6.7% | $0.620 | $0.630 | $0.540 | 345,900 | |
| $0.600 | -0.050 | -7.7% | $0.650 | $0.670 | $0.590 | 372,000 | |
| $0.650 | +0.040 | +6.6% | $0.650 | $0.690 | $0.630 | 408,700 | |
| $0.610 | -0.090 | -12.9% | $0.670 | $0.670 | $0.590 | 481,000 | |
| $0.700 | +0.070 | +11.1% | $0.680 | $0.700 | $0.660 | 362,400 | |
| $0.630 | +0.030 | +5.0% | $0.710 | $0.800 | $0.560 | 7,324,100 | |
| $0.600 | -0.090 | -13.0% | $0.710 | $0.720 | $0.590 | 615,300 | |
| $0.690 | +0.060 | +9.5% | $0.680 | $0.720 | $0.660 | 374,300 | |
| $0.630 | -0.020 | -3.1% | $0.630 | $0.640 | $0.610 | 186,100 | |
| $0.650 | +0.110 | +20.4% | $0.550 | $0.680 | $0.540 | 464,300 | |
| $0.540 | +0.070 | +14.9% | $0.490 | $0.570 | $0.450 | 239,200 | |
| $0.470 | -0.020 | -4.1% | $0.490 | $0.540 | $0.460 | 69,000 | |
| $0.490 | +0.010 | +2.1% | $0.510 | $0.510 | $0.470 | 70,900 |
- Ticker
- NASDAQ:EVGN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
Latest earnings call · Aug 18, 2026
Evogene (NASDAQ:EVGN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 27, 2026
Investor Presentation (August 2026)
Investor deck · 32 slides
Calls
Replays
Evogene (NASDAQ:EVGN) Q2 2026 Earnings Call
Tue, Aug 18, 2026 · 9:00 AM ET
Watch TranscriptEvogene (NASDAQ:EVGN) Q1 2026 Earnings Call
Wed, May 20, 2026 · 9:00 AM ET
Watch TranscriptEvogene (NASDAQ:EVGN) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 9:00 AM ET
Watch Transcript
Latest news
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
Oct 28, 2026
Closed $0.374 (+2.9%) on Oct 28, 2026
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
Oct 26, 2026
Closed $0.37 (+2.8%) on Oct 26, 2026
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
Oct 20, 2026
Closed $0.37 (0.0%) on Oct 20, 2026
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Oct 6, 2026
Closed $0.41 (-2.4%) on Oct 7, 2026
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
Sep 30, 2026
Closed $0.40 (-2.4%) on Sep 30, 2026
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Aug 31, 2026
Closed $0.54 (-1.8%) on Aug 31, 2026
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
Aug 25, 2026
Closed $0.55 (-1.8%) on Aug 25, 2026
Evogene Reports Second Quarter and First Half 2026 Financial Results
Aug 18, 2026
Closed $0.58 (+3.6%) on Aug 18, 2026
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
Aug 14, 2026
Closed $0.60 (-7.7%) on Aug 14, 2026
Evogene Schedules Second Quarter 2026 Financial Results Release
Jul 30, 2026
Closed $0.49 (+2.1%) on Jul 30, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 32 slides · Aug 27, 2026
Q2 2026 Earnings Presentation
Earnings · 18 slides · Aug 18, 2026
Investor Presentation (June 2026)
Investor deck · 32 slides · Jun 16, 2026
Q1 2026 Earnings Presentation
Earnings · 27 slides · May 20, 2026
Evogene Ltd. on 6ix
- News releases
- 36 in the last 12 months · 111 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 18, 2026
- Decks
- 51 decks · latest Aug 27, 2026
Where Evogene Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EVGN · Home listing · This page | NASDAQ | United States | USD |
| TASE:EVGN | TASE | Israel | ILA |
| BOATS:EVGN | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Evogene Ltd.